Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 90 results for "mylan"

Delhi HC rejects Sun Pharma appeal in Oxaliplatin case against...

Despite noting importance of first syllable of trade name, HC didn't find 'Ox' and 'Sox' similar Business Standard, 2 days ago

1,768 images for mylan

Reuters, 3 days ago
Money Control, 1 week ago
The Telegraph UK, 1 week ago
Money Control, 3 weeks ago
Business Standard, 1 month ago
SleekMoney, 1 month ago
SleekMoney, 1 month ago
Investing.com, 1 month ago
Investing.com, 1 month ago
CNBC, 1 month ago
Business Standard

Mylan inks settlement pact with Genentech & Roche on cancer drug Herceptin

Trastuzumab (Herceptin) is one of the 6 biologic products co-developed by Mylan & Biocon BS B2B Bureau | Pittsburgh, USA March 14, 2017 Last Updated at 16:28 IST Mylan NV has agreed to the terms of a global settlement with Genentech Inc and F. Hoffmann-La ...
 Business Standard1 week ago Biocon and Mylan get USFDA approval to jointly develop biologic product  First Post.com1 month ago US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim  Business Standard1 month ago FDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim  DNA1 month ago
Money Control

Biocon, Alkem Labs surge on US FDA nods to products

Biocon surged after Mylan got a nod for breast cancer tablets, while Alkem Labs rose due to a nod for an ointment to treat ventricular tachycardia.
 Money Control1 week ago Biocon chief sees anti-cancer biosimilar launch in FY19  Money Control1 month ago US nod for Biocon-Mylan biosimilar  Business Line2 months ago Biosimilar developed by Biocon, Mylan  Business Line2 months ago
Money Control

Analysts cheer Mylan-Roche settlement, upbeat on Biocon

Feel better product launch visibility and first movers advantage to aid its financials; largely maintain buy call on the stock
 Money Control1 week ago

Mylan deal removes uncertainty over launch of Trastuzumab biosimilar: Biocon Chief

Global healthcare company Mylan has inked a settlement pack with Genentech and Roche in relation to patents for cancer drug Herceptin (Trastuzumab).
 Money Control1 week ago

Mylan deal clears path for biosimilar copy of Roche's Herceptin

LONDON (Reuters) - Generic drugmaker Mylan said on Monday it had reached a settlement with Roche providing "a clear pathway" for the launch of its biosimilar version of the Swiss company's top-selling breast cancer drug Herceptin in major markets.
 Business Standard1 week ago

HC allows Biocon, Mylan to sell their drug for three cancers

The Delhi High Court today allowed drug companies Biocon and Mylan to sell their version of Trastuzumab for two kinds of breast cancer and metastatic gastric cancer in view of the approval granted to it by the Drugs Controller General of India (DCGI).
 DNA3 weeks ago Setback for Roche: Mylan, Biocon can now sell generics of its cancer drug  Business Standard3 weeks ago

According to Biocon and Mylan, their respective breast

Biocon and Mylan have taken the stand that Roche no longer holds a patent in India for Trastuzumab.
 DNA1 month ago Can Biocon, Mylan drugs be used for early breast cancer: HC  DNA1 month ago
Business Line

Natco gets a booster dose on favorable patent ruling in US

Natco and Mylan believe that they are the first companies to have filed a substantially complete abbreviated new drug application containing a Para-IV certification for a 3 times per week Glatiramer Acetate Injection 40 mg/mL, and expect 180 days of marketing ...
 Money Control1 month ago Natco Pharma climbs after partner wins patent case in US  DNA1 month ago US Court rules in favour of Mylan for Copaxone patents: Natco  DNA1 month ago
[x]  

USFDA accepts Mylan's application for proposed biosimilar

It has got acceptance of regulatory filings in Europe, Australia and Canada
 Business Standard1 month ago Biocon scales record high as USFDA accepts BLA for proposed biosimilar Trastuzumab  Business Standard2 months ago USFDA to review Biocon-Mylan's biosimilar drug for breast cancer  Money Control2 months ago Biocon at new high; FDA accepts BLA for biosimilar Pegfilgrastim  Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less